Trulieve Cannabis (OTC: TCNNF)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.030 | 0.010 | -0.0200 | ||||
REV | 307.080M | 318.300M | 11.220M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Trulieve Cannabis (OTCQX: TCNNF) through any online brokerage.
There are no as such competitors for Trulieve Cannabis.
The latest price target for Trulieve Cannabis (OTCQX: TCNNF) was reported by Cantor Fitzgerald on Friday, May 13, 2022. The analyst firm set a price target for 57.00 expecting TCNNF to rise to within 12 months (a possible 396.26% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Trulieve Cannabis (OTCQX: TCNNF) is $11.486 last updated July 1, 2022, 7:58 PM UTC.
There are no upcoming dividends for Trulieve Cannabis.
Trulieve Cannabis’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Trulieve Cannabis.
Trulieve Cannabis is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQX.